Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis
This study has been withdrawn prior to enrollment.
(Sponsor withdrew study for business reasons)
Human Genome Sciences Inc., a GSK Company
Information provided by (Responsible Party):
GlaxoSmithKline ( Human Genome Sciences Inc., a GSK Company )
First received: September 1, 2011
Last updated: October 29, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||No date given|
|Estimated Primary Completion Date:||December 2012 (Final data collection date for primary outcome measure)|